The Wiener Lab laboratory, with a production plant in Rosario, will be the first in the country to produce the rapid self-test for the indicative detection of the coronavirus, as reported, after this Friday it received approval from the National Administration of Medicines, Food and Technology Medical (Anmat). You will be able to manufacture this product that will be sold “free” in pharmacies and drugstores throughout the country.
“This test makes it possible to determine the presence or absence of antigens (proteins) of the SARS-CoV-2 virus,” the company’s president, Federico Rojkin, explained to Télam, adding that “it is a simple test that can be carried out by any person over the age of 18 in your home.
See also: The ANMAT approved the sale in pharmacies of the self-test to detect Covid-19
He also clarified “that the result is indicative. It does not confirm or rule out the infection,” said the manager.
Rojkin admitted that since Anmat’s approval, the laboratory is working “against the clock” to supply pharmacies and drugstores as soon as possible.
The new production line requires an investment of $85 million from the laboratory to expand production.
See also: The ANMAT gave the green light to another COVID-19 self-test and there are already five authorized in the country
“Wiener Lab. has more than 300 employees in Rosario. We are working as a team and redirecting all efforts to meet the demand,” said the biochemist who graduated from the National University of Rosario (UNR).
In addition, he said that since the pandemic began, the company – founded 60 years ago by his father Miguel, also a biochemist and researcher – “manufactured 500,000 PCR tests and 10,000 rapid antigen tests for professional use.”
Along these lines, Rojkin emphasized “that Wiener Lab. is so far the only national company authorized to manufacture and market Covid-19 self-tests,” adding that the laboratory’s main objective “is to provide a national industry tool to all Argentines and, in principle, to be able to supply the local market and all the pharmacies that require it,” he said.
In this regard, the biochemist did not rule out that the product “later on can be exported to different countries in the region where we have 10 of our own subsidiaries,” he stated.
How is the test and how much will it cost?
The components of the kit are a cassette with lateral flow technology that uses commercial antibodies linked to nanoparticles; includes a swab for taking the nasal sample and a solution for the treatment; and the result can be obtained in 15 minutes.
“The marketing of self-tests will be through pharmacies and drugstores, so companies and private consumers will have to obtain supplies through these channels,” said Rojkin. Regarding the public sale price of the kits, he indicated that they will be sold on the local market at around $3,000 or $4,000.
According to information from Anmat, the agency recently authorized three other companies to develop the tests; Roche laboratories from Switzerland, Abbot from the United States and a third party that will import from abroad.
Thus, the company from Rosario is the only one with national capital authorized for the national industrial development of the product that, according to initial estimates, could be for sale in the country’s pharmacies in the coming weeks.